Laboratory Co. of America Holdings (NYSE:LH) Shares Sold by Schroder Investment Management Group

Schroder Investment Management Group trimmed its holdings in shares of Laboratory Co. of America Holdings (NYSE:LH - Free Report) by 24.6% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 5,554 shares of the medical research company's stock after selling 1,810 shares during the period. Schroder Investment Management Group's holdings in Laboratory Co. of America were worth $1,274,000 at the end of the most recent quarter.

Other large investors have also made changes to their positions in the company. Graney & King LLC acquired a new position in Laboratory Co. of America during the fourth quarter valued at $26,000. Fortitude Family Office LLC lifted its holdings in shares of Laboratory Co. of America by 312.5% in the 4th quarter. Fortitude Family Office LLC now owns 132 shares of the medical research company's stock valued at $30,000 after buying an additional 100 shares during the period. Geneos Wealth Management Inc. boosted its stake in shares of Laboratory Co. of America by 309.8% in the fourth quarter. Geneos Wealth Management Inc. now owns 168 shares of the medical research company's stock worth $39,000 after buying an additional 127 shares during the last quarter. Human Investing LLC purchased a new stake in shares of Laboratory Co. of America in the fourth quarter worth about $39,000. Finally, Heck Capital Advisors LLC acquired a new stake in Laboratory Co. of America during the fourth quarter worth about $44,000. 95.94% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several equities research analysts have commented on LH shares. Jefferies Financial Group upped their price objective on Laboratory Co. of America from $275.00 to $290.00 and gave the stock a "buy" rating in a research report on Thursday, February 6th. UBS Group lowered their price target on shares of Laboratory Co. of America from $293.00 to $286.00 and set a "buy" rating on the stock in a report on Tuesday, January 28th. Truist Financial cut their price objective on shares of Laboratory Co. of America from $285.00 to $274.00 and set a "buy" rating for the company in a report on Friday. StockNews.com raised shares of Laboratory Co. of America from a "hold" rating to a "buy" rating in a research note on Sunday, April 6th. Finally, Evercore ISI upgraded Laboratory Co. of America from an "in-line" rating to an "outperform" rating and lifted their price target for the company from $260.00 to $265.00 in a research note on Tuesday, January 7th. Three analysts have rated the stock with a hold rating, twelve have issued a buy rating and one has given a strong buy rating to the company's stock. Based on data from MarketBeat, the company presently has an average rating of "Moderate Buy" and an average target price of $268.77.

Remove Ads

Laboratory Co. of America Price Performance

Shares of NYSE:LH traded up $2.85 during trading on Friday, reaching $221.46. The stock had a trading volume of 1,031,685 shares, compared to its average volume of 638,269. The business has a fifty day moving average price of $240.04 and a 200-day moving average price of $234.81. Laboratory Co. of America Holdings has a 1-year low of $191.97 and a 1-year high of $258.59. The company has a debt-to-equity ratio of 0.67, a quick ratio of 1.30 and a current ratio of 1.44. The stock has a market cap of $18.54 billion, a PE ratio of 25.11, a PEG ratio of 1.71 and a beta of 0.99.

Laboratory Co. of America (NYSE:LH - Get Free Report) last released its earnings results on Thursday, February 6th. The medical research company reported $3.45 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $3.40 by $0.05. Laboratory Co. of America had a net margin of 5.73% and a return on equity of 15.29%. On average, equities analysts forecast that Laboratory Co. of America Holdings will post 16.01 earnings per share for the current fiscal year.

Laboratory Co. of America Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, June 11th. Shareholders of record on Thursday, May 29th will be paid a $0.72 dividend. This represents a $2.88 dividend on an annualized basis and a yield of 1.30%. Laboratory Co. of America's dividend payout ratio (DPR) is 32.65%.

Insider Transactions at Laboratory Co. of America

In other news, EVP Amy B. Summy sold 758 shares of Laboratory Co. of America stock in a transaction on Friday, March 28th. The stock was sold at an average price of $231.67, for a total transaction of $175,605.86. Following the transaction, the executive vice president now owns 5,302 shares in the company, valued at $1,228,314.34. The trade was a 12.51 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Kerrii B. Anderson sold 500 shares of the company's stock in a transaction dated Wednesday, March 5th. The shares were sold at an average price of $255.63, for a total transaction of $127,815.00. Following the completion of the sale, the director now directly owns 13,166 shares of the company's stock, valued at $3,365,624.58. This represents a 3.66 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 14,258 shares of company stock worth $3,518,177 in the last ninety days. Insiders own 0.85% of the company's stock.

Laboratory Co. of America Company Profile

Labcorp Holdings, Inc engages in providing medical testing services. The company was founded on April 16, 2024 and is headquartered in Burlington, NC.